Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dicentric (1;15) in myeloid disorders

L Michaux1, J Dierlamm, C Mecucci

  • 1Center for Human Genetics, Katholieke Universiteit Leuven, Belgium.

Cancer Genetics and Cytogenetics
|May 1, 1996
PubMed
Summary

Researchers identified a specific chromosomal anomaly, dic(1;15)(p11;p11), in three myeloid disorder cases. This finding suggests a reclassification of six previously reported t(1;15) cases, highlighting a common genetic abnormality in myeloid disorders.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical Epidemiology.

Acta clinica Belgica·2016
Same author

The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.

Oncogene·2014
Same author

Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and long-term survival in an adult patient.

Blood cancer journal·2014
Same author

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.

Leukemia·2013
Same author

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.

Leukemia·2013

Area of Science:

  • Cytogenetics
  • Hematology
  • Oncology

Background:

  • Myeloid disorders encompass a range of hematologic malignancies.
  • Chromosomal abnormalities are key drivers in myeloid disorder development.
  • Specific translocations, such as t(1;15), have been implicated.